|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Nitroprusside#Pharmacology]] |
| {{Nitroprusside}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Description==
| |
| | |
| Sodium nitroprusside is disodium pentacyanonitrosylferrate(2-) dihydrate, a hypotensive agent whose structural formula is
| |
| | |
| {|
| |
| |[[File:nitropress03.jpg|thumb|800px]]
| |
| |}
| |
| Sodium Nitroprusside
| |
| | |
| whose molecular formula is Na2[Fe(CN)5NO] • 2H2O, and whose molecular weight is 297.95. Dry sodium nitroprusside is a reddish-brown powder, soluble in water. In an aqueous solution infused intravenously, sodium nitroprusside is a rapid-acting vasodilator, active on both arteries and veins.
| |
| | |
| Sodium nitroprusside solution is rapidly degraded by trace contaminants, often with resulting color changes. (See DOSAGE AND ADMINISTRATION section.) The solution is also sensitive to certain wavelengths of light, and it must be protected from light in clinical use.
| |
| | |
| NITROPRESS (Sodium Nitroprusside Injection) is available as:
| |
| | |
| 50 mg Fliptop Vial – Each 2 mL vial contains the equivalent of 50 mg sodium nitroprusside dihydrate in sterile water for injection.
| |
| | |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NITROPRESS (SODIUM NITROPRUSSIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a44bcac-a0e1-4069-5691-db7b83dbb4b7 | publisher = | date = | accessdate = 27 February 2014 }}</ref>
| |
| | |
| ==References ==
| |
| {{Reflist|2}}
| |
| | |
| {{Nonsympatholytic vasodilatory antihypertensives}}
| |
| | |
| [[Category:Cyanides]]
| |
| [[Category:Vasodilators]]
| |
| [[Category:Coordination compounds]]
| |
| [[Category:World Health Organization essential medicines]]
| |
| [[Category:Iron compounds]]
| |
| [[Category:Nitrosyl compounds]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |